OPEN-LABEL in Chinese translation

• 开放标签

Examples of using Open-label in English and their translations into Chinese

In this open-label, phase I dose-escalation trial, the investigators enrolled 13 patients with histologically confirmed esophageal cancer deemed unfit to receive standard surgery or chemotherapy;
在这项开放标签的I期剂量递增试验中，研究人员招募了13名患有组织学证实的食管癌的患者，这些患者被认为不适合接受标准手术或化疗;

In this one-week, open-label, multiple-dose phase one clinical trial, 17 boys(mean age 5.5 years) were administered three sequential ascending doses of edasalonexent(33, 67, and 100 mg/kg/day).
在为期一周的开放标签，多剂量1期临床试验中，17名男孩(平均年龄5.5岁)接受三次连续递增剂量的edasalonexent(33,67和100mg/kg/天)。

Participants received either 40-IU of placebo or insulin(Humulin-RU100, Eli Lilly) daily for 12 months, followed by a 6-month open-label extension(OLE).
被试每天接受40IU的安慰剂或胰岛素（Humulin-RU100，EliLilly），持续12个月，然后是6个月的开放标签延长观察期。

This is a single-arm, open-label pilot study.
这是一个单臂，开放标签的试验。

This is a single-arm, open-label pilot study.
这是一项单臂、开放标签研究。

This was a small, single-arm, open-label study.
这是一项单臂、开放标签研究。

This was a phase II, single arm, open-label study.
这是一项单臂、开放标签研究。

The present study describes the results of a 16-week open-label extension.
本研究描述了16周开放标签扩展结果。

This will be a randomized, open-label, multicenter, phase II study.
这是一项开放性、多中心、二阶段、II期研究。

Axovant said it will work with investigators to conclude the MINDSET open-label extension study.
Axovant公司表示，将与研究人员一起合作完成MINDSET开放标签扩展研究。

RESPONSE is a global, randomized, open-label study conducted at 109 sites.
RESPONSE是一项全球性、随机、开放标签研究，在全球109个位点开展。

All studies were considered at high risk for performance bias as they were open-label studies.
所有研究都被认为具有高风险的实施偏倚，因为它们是开放标签研究。

This is a 4-stage, non-randomized, open-label, dose escalation and expansion, multicenter study.
这是一项四阶段，非随机，开放标签，剂量升高和扩张的多中心研究。

This randomised, open-label, phase 3 study was done at 148 medical centres in 30 countries.
这项3期随机、开放性研究在30个国家的148个医学中心开展。

The ELLIPSE trial included a 26-week, double-blinded treatment period followed by a 26-week open-label extension period.
ELLipsE研究包括一个26周的双盲治疗期，随后是26周的开放标签扩展期。

SAFETY of Intrarosa was established in four 12-week placebo-controlled trials and one 52-week open-label trial.
Intrarosa的安全性在4项为期12周的安慰剂对照研究和一项为期52周的标签中得到了确认。

Methods GLOBAL LEADERS was a randomised, open-label superiority trial at 130 sites in 18 countries.
方法：GLOBALLEADERS是一项随机、开放标签优越性试验，在18个国家的130个地区进行。

Long-term safety of XCOPRI has been evaluated in the ongoing open-label extensions of the randomized studies and the open-label safety study.
Xcopri的长期安全性已经在随机研究和开放标签安全性研究的开放标签扩展中进行了评估。

RESPONSE is a global, randomized, open-label study conducted at more than 90 trial sites.
RESPONSE是一项全球性、随机、开放标签研究，在全球109个位点开展。

The safety of Intrarosa was established in four 12-week placebo-controlled trials and one 52-week open-label trial.
Intrarosa的安全性在4项为期12周的安慰剂对照研究和一项为期52周的标签中得到了确认。